Merus

+$2.80 (+12.42%) As of 7:35 PM UTC today

Why Robinhood?

You can buy or sell Merus and other stocks, options, and ETFs commission-free!

About MRUS

Merus N.V. Common Shares, also called Merus, is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics.

CEO
Sven Ante Lundberg
Employees
—
Headquarters
Utrecht, Utrecht
Founded
2003

MRUS Key Statistics

Market Cap
966.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
96.56K
High Today
$25.37
Low Today
$22.79
Open Price
$22.99
Volume
178.18K
52 Week High
$31.27
52 Week Low
$10.18

MRUS Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.68 per share
Actual
-$0.28 per share

You May Also Like

PIPP+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure